BEAM | Complete Beam Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Beam Therapeutics (BEAM): A Small-Cap Leader in Precision Genetic Medicine (Insider Monkey) Oct-17-24 03:05PM State Street Corp's Strategic Acquisition in Beam Therapeutics Inc (GuruFocus.com)-8.77% Sep-05-24 11:31AM Why Is Beam Therapeutics (BEAM) Down 1.6% Since Last Earnings Report?
in-depth analysis, and powerful stock ratings. create free account bull or bear, seeking alpha is there markets change, but our community always has the latest news, in-depth analysis, and powerful stock ratings. create free account beam beam therapeutics inc. stock price & overview follow $ ...
Market Cap $2B Current Price $14.67 NASDAQ: CRSP CRISPR Therapeutics Market Cap $3B Current Price $40.94 NASDAQ: KNSA Kiniksa Pharmaceuticals International, Plc Market Cap $1B Current Price $19.94 NASDAQ: AMPH Amphastar Pharmaceuticals Market Cap ...
Beam Therapeutics (BEAM) has a Smart Score of 6 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity.
Beam Therapeutics Beta is currently at 1.86. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equ
Market Cap 0.39B Stock Price 13.30 Revenue $0000 About Ion Beam Applications Ion Beam Applications is involved in particle accelerator technology and operates within the healthcare and industrial sectors. The company provides equipment and services for proton therapy, a type of radiation therapy, as ...